Key facts
- This page summarizes William P. Murphy Jr.'s Form 4 filing for U.S. Stem Cell, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Jul 2021, 16:03.
William P. Murphy Jr. - 23 Feb 2021 Form 4 Insider Report for U.S. Stem Cell, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 23 Feb 2021
- Net transaction value
- +$200,000
- Reporting owner signature
- /s/ William P. Murphy Jr
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
William P. Murphy Jr. filed Form 4 for U.S. Stem Cell, Inc. on 23 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$200,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USRM
transaction
Common Stock
Award
- Transaction value
- $200,000
- Shares
- +7,518,797
- Change %
- +410%
- Price
- $0.0266
- Shares after
- 9,352,603
- Date
- 23 Mar 2021
- Ownership
- Spouse
- Footnotes
- F1
USRM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,092,719
- Date
- 23 Feb 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Derived from the full Conversion of a Convertible Debenture, dated February 23, 2021.